PGE2 plays a critical role in suppressing the response of CD8+ T Cells to interleukin-2 (IL-2) signaling, thereby preventing the expansion of stem-like CD8+ T Cells and tumor-infiltrating CD8+ T Cells. The gene discussed is CD8A; the disease is neoplasm.